| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 03/23/1999 | US5886243 Genetic engineering of wood color in plants |
| 03/23/1999 | US5886166 Viricides; htlv; a trna primer for reverse transcription of a murine leukemia virus retroviral transfer vector having sequences in the primer binding site replaced to prevent strong base pairing with naturally occuring trna |
| 03/23/1999 | US5886165 Mixed backbone antisense oligonucleotides containing 2'-5'-ribonucleotide- and 3'-5'-deoxyribonucleotides segments |
| 03/23/1999 | US5886164 DNA encoding enzymes related to ethylene biosynthesis and ripening from banana |
| 03/23/1999 | US5886163 A recombinant nucleic acid molecule which encodes a mutant hiv-1 gp120 envelope glycoprotein comprising a v3 loop deletion and a c4 domains.sub.(w.fwdarw.x) point mutation, wherein x is an amino acid residue other than tryptophan |
| 03/23/1999 | US5886153 Antibodies directed against the alpha interferon receptor |
| 03/23/1999 | US5886152 Humanized antibody produced by transplantation of complementarity-determining region of a mouse monoclonal antibody b-b10 specific to a human interleukin-2 receptor into a human antody; genetic engineering |
| 03/23/1999 | US5886150 Peptides capable of binding to the GAP protein SH3 domain, nucleotide sequences coding therefor, and preparation and use thereof |
| 03/23/1999 | US5886145 Isolated nucleic acid molecules, peptides which form complexes with MHC molecule HLA-A2 and uses thereof |
| 03/23/1999 | US5885971 Gene therapy by secretory gland expression |
| 03/23/1999 | US5885970 Antisense oligonucleotides against human protein kinase C |
| 03/23/1999 | US5885963 Administering to said pests, or the environment of said pests, a pesticidally effective amount of a bacillus thuringiensis delta-endotoxin from the bacillus thuringiensis isolate ps123d1 |
| 03/23/1999 | US5885962 Stem cell factor analog compositions and method |
| 03/23/1999 | US5885961 Methods of using epithelins to modulate cell proliferation |
| 03/23/1999 | US5885836 FLP-mediated gene modification in mammalian cells, and compositions and cells useful therefor |
| 03/23/1999 | US5885834 Inducing apoptosis in cell by identifying phosphodiesterase pde1b1 in cell line comprising said cancer cell, synthesizing antisense oligodeoxynucleotide asodn inhibitor to bind to mrna coding pde1b1, applying asodn to cell to induce apoptosis |
| 03/23/1999 | US5885833 Nucleic acid constructs for the cell cycle-regulated expression of genes and therapeutic methods utilizing such constructs |
| 03/23/1999 | US5885832 Human lens epithelial cell line |
| 03/23/1999 | US5885831 A protein encoded by drosophila timeless gene; a kit useful for diagnosis and treatment of disorders related to sleep wake cycle |
| 03/23/1999 | US5885828 SecA gene of mycobacterium tuberculosis and related methods and compositions |
| 03/23/1999 | US5885827 Eukaryotic high rate mutagenesis system |
| 03/23/1999 | US5885821 Process for production of a protein with kex2 protease enzyme activity, wherein said protein has a shortened amino acid sequence whose n-terminus is met at amino acid position 1 by culturing dna transformed methylotrophic yeast cells |
| 03/23/1999 | US5885819 Genetic engineered hybrid dna encoding xylanase, used for degrading plant cell wall components e.g. in the preparation of animal feeds, in food baking, in papermaking and pulp industry and separation of wheat into starch and gluten |
| 03/23/1999 | US5885818 Culturing a host cell transformed with genetic engineered dna vector under conditions suitable for expression of agei restriction endonucleases |
| 03/23/1999 | US5885814 Vaccine containing a serine protease |
| 03/23/1999 | US5885813 Thermostable DNA polymerases |
| 03/23/1999 | US5885811 Leader sequence inducing a post-translational modification of polypeptides in bacteria gene therefor and subtilin variant of enhanced stability and activity |
| 03/23/1999 | US5885810 Process for the production of prenyl diphosphate using mutants of geranylgeranyl diphosphate synthase |
| 03/23/1999 | US5885808 Genetically modifying adenovirus or adenovirus like particle to produce a binding site which is incorporated as a fusion protein with fiber protein, infecting cells with above viruses, culturing and harvesting |
| 03/23/1999 | US5885806 Methods to prepare conditionally replicating viral vectors |
| 03/23/1999 | US5885805 gbpA |
| 03/23/1999 | US5885804 Genetic engineered polynucleotides and encoded polypeptides of the atp-binding protein family, treating meningitis, infection of cerebrospinal fluid |
| 03/23/1999 | US5885802 High methionine derivatives of α-hordothionin |
| 03/23/1999 | US5885801 Protein enriched in threonine residues which can be expressed in plants used for foods or animal feeds |
| 03/23/1999 | US5885800 DNA encoding tumor necrosis related receptor, TR4 |
| 03/23/1999 | US5885799 Hepatitis C virus protease |
| 03/23/1999 | US5885798 Isolated polynucleotide sequence encoding the polypeptide comprising the given amino acid sequence |
| 03/23/1999 | US5885795 Methods of expressing angiostatic protein |
| 03/23/1999 | US5885794 Recombinant production of vertebrate activin receptor polypeptides and identification of receptor DNAs in the activin/TGF-β superfamily |
| 03/23/1999 | US5885793 Production of anti-self antibodies from antibody segment repertoires and displayed on phage |
| 03/23/1999 | US5885792 Biotin operon |
| 03/23/1999 | US5885783 Autoimmune inner ear disease antigen and diagnostic assay |
| 03/23/1999 | US5885780 Method of obtaining small conformationally rigid conopeptides |
| 03/23/1999 | US5885779 Repressed trans-activator system for characterization of protein-protein interactions |
| 03/23/1999 | US5885777 A nucleotide sequence encoding an active phosphatidylinositol-3-kinase consisting of specific amino acid sequences or a nucleotide sequence which hybridizes with above nucleotide sequences after washing in low salt buffer |
| 03/23/1999 | US5885768 Immunogenic peptides derived from the orf1, orf2, and orf3 regions of hepatitis e virus (hev), diagnostic reagents containing the peptide antigens, vaccine compositions containing the antigens, antibodies |
| 03/23/1999 | US5885585 Virus derived from 65th passage of cpv-39; vaccines against canine parvovirus or feline panleukopenia virus |
| 03/23/1999 | US5885577 Possess binding specificities that are similar to the binding specificities of the antibodies or receptors; may be used in place of antibodies in many assays or therapeutic applications |
| 03/23/1999 | US5885575 Diagnosis and therapy of tumour metastases |
| 03/23/1999 | US5885574 Antibodies which activate an erythropoietin receptor |
| 03/23/1999 | US5885573 Methods and materials for modulation of the immunosuppressive activity and toxicity of monoclonal antibodies |
| 03/23/1999 | US5885572 Administering polypeptide or active fragment to treat bacterial infections |
| 03/23/1999 | US5885571 Bacillus thuringiensis strains and their insecticidal proteins |
| 03/23/1999 | US5885569 Biological insect control agent |
| 03/23/1999 | US5885568 Coccidiosis poultry vaccine |
| 03/23/1999 | US5885567 Treatment of infection in fowl by oral administration of avian interferon proteins |
| 03/23/1999 | CA2248622A1 Biolistic apparatus for delivering substances into cells and tissues |
| 03/23/1999 | CA2140910C An improved method of agrobacterium-mediated transformation of cultured soybean cells |
| 03/23/1999 | CA2127462C Treatment for asthma |
| 03/23/1999 | CA2099508C Compact detergent compositions with high activity cellulase |
| 03/23/1999 | CA2077405C Virus resistant plants and method therefore |
| 03/23/1999 | CA1340461C Alveolar surfactant proteins |
| 03/23/1999 | CA1340459C Method to produce immunodiagnostic reagents |
| 03/23/1999 | CA1340456C Chimeric rodent/human immunoglobulins specific for tumor-associated antigens |
| 03/23/1999 | CA1340455C Human preproinsulin-like growth factor i |
| 03/23/1999 | CA1340454C Diuretic peptide and gene coding same |
| 03/23/1999 | CA1340453C Human atrial natriuretic peptide and gene coding for same |
| 03/22/1999 | CA2244239A1 Novel era |
| 03/22/1999 | CA2244237A1 A human lig-1 homolog (hlig-1) |
| 03/19/1999 | CA2244970A1 Truncated cellulase compositions |
| 03/19/1999 | CA2244880A1 Synuclein-based assay and novel synuclein protein |
| 03/19/1999 | CA2216057A1 Polymorphic cag repeat-containing gene, diagnosis of psychiatric diseases and therapeutic uses thereof |
| 03/19/1999 | CA2215870A1 Method for the identification of essential genes and therapeutic targets |
| 03/19/1999 | CA2211003A1 Human tumor necrosis factor receptor |
| 03/18/1999 | WO1999013313A1 Method of making high density arrays |
| 03/18/1999 | WO1999013113A1 Non-competitive co-amplification methods |
| 03/18/1999 | WO1999013111A1 Reagents and methods useful for detecting diseases of the prostate |
| 03/18/1999 | WO1999013107A1 A method for determining the in vivo function of dna coding sequences |
| 03/18/1999 | WO1999013105A1 Method for the preparation of a probe for nucleic acid hybridization |
| 03/18/1999 | WO1999013104A1 Diagnosis of ocular pathogens |
| 03/18/1999 | WO1999013102A1 Method for marking solid, liquid or gaseous substances |
| 03/18/1999 | WO1999013097A1 Stabilization of helicobacter urease |
| 03/18/1999 | WO1999013096A1 Materials and methods for intracellular delivery of biologically active molecules |
| 03/18/1999 | WO1999013095A2 Use of multivalent chimeric peptide-loaded, mhc/ig molecules to detect, activate or suppress antigen-specific t cell-dependent immune responses |
| 03/18/1999 | WO1999013094A2 Fungal pathogenicity genes |
| 03/18/1999 | WO1999013093A1 Expression vector for improved production of polypeptides in yeast |
| 03/18/1999 | WO1999013092A1 Enhancement of mucosal antibody responses by interleukin-6 |
| 03/18/1999 | WO1999013091A1 Fusion protein systems |
| 03/18/1999 | WO1999013090A1 Regulation of protein secretion |
| 03/18/1999 | WO1999013089A1 Nucleic acid sequences to reduce another dehiscence |
| 03/18/1999 | WO1999013088A1 Novel human manganese superoxide dismutase proteins |
| 03/18/1999 | WO1999013087A1 Novel protoporphyrinogen oxidase tolerant to light-requiring herbicides |
| 03/18/1999 | WO1999013086A1 PROTEIN WITH THE AMINO ACID SEQUENCE OF Δ7 STEROL REDUCTASE, ISOLATED cDNA MOLECULE CODING FOR SAID PROTEIN, RECOMBINANT DNA VECTOR AND BIOLOGICALLY ACTIVE COMPOSITIONS CONTAINING SAID PROTEIN OR SAID cDNA MOLECULE |
| 03/18/1999 | WO1999013085A2 MICROBIAL GENES FOR SECRETED β-GLUCURONIDASES, GENE PRODUCTS AND USES THEREOF |
| 03/18/1999 | WO1999013084A1 Group a streptococcal vaccines |
| 03/18/1999 | WO1999013083A2 Method and means for modulating plant cell cycle proteins and their use in controlling plant cell growth |
| 03/18/1999 | WO1999013082A1 Cxc chemokine |
| 03/18/1999 | WO1999013081A1 EXPRESSION OF GONADOTROPINS IN $i(DICTYOSTELIUM) |
| 03/18/1999 | WO1999013080A1 Beta-defensins |
| 03/18/1999 | WO1999013079A1 Rin2, a novel inhibitor of ras-mediated signaling |